This is BrainsWay’s global website. The global website is not intended for persons in the United States and includes information on clinical indications that were not cleared by the FDA, which are subject to further US regulatory review for safety and efficacy. BrainsWay D is cleared by the FDA only for patients with MDD who failed to respond to one or more anti-depressants in the current episode, and for patients with OCD as an adjunct treatment.
Message from the Head
The Department of Psychiatry at the University of Minnesota strives to fulfill the tripartite mission of the Medical School: excellence in teaching, research and clinical service.
The Department conducts cutting edge research that leads to a fundamental understanding of psychiatric disease and to the development of new and safe treatments for these diseases.
The Department provides outstanding inpatient and outpatient clinical care as a base for teaching medical students and residents at the University as well as providing specialized programs for patients and their families, including Deep TMS therapy.
Teaching is to provide original, stimulating and state of art knowledge to trainees at all levels from the first year of medical school to the completion of post residency fellowships.
Please fill all the marked fields